McRoberts integrates the Mobilise-D algorithm for computing Digital Mobility Outcomes in its analytics pipeline for use in clinical trials and healthcare.
The Hague - 1 October 2024. With the recent conclusion of the Mobilise-D project, McRoberts is now ready to take the next steps: facilitating the adoption of the Mobilise-D Digital Mobility Outcomes (DMOs) in healthcare and clinical trials. They have integrated the Mobilise-D algorithm into their analytics pipeline, enabling them to offer the 25 Mobilise-D measures to their clients. This enhancement allows McRoberts to process and analyze both newly collected data and existing mobility datasets.
Their five-year involvement in the project has equipped the long-standing company with extensive experience and the necessary tools to support clients in exploiting these advancements in digital health technology. McRoberts role within Mobilise-D was to provide wearable sensors, to facilitate sensor data collection and to analyse the mobility data using their MoveMonitor and MoveTest algorithms.
"The conclusion of this groundbreaking project marks a major milestone in the field of daily-life mobility monitoring, and for our company," says Martijn Niessen, CEO of McRoberts. "We've been monitoring physical activity for over 25 years but widespread adoption by the healthcare and pharmaceuticals communities was lacking for various reasons. Validated measures, a framework for implementation, and maturing technology will drive the revolution of digital biomarkers in studies. Because of Mobilise-D, these conditions have been established for implementing daily-life mobility assessment in studies. Over 20,000 measurements were collected and processed using our technology during the Mobilise-D project, so we're well equipped to embark on the next steps."
Randomized controlled trials are essential to uncover the full potential of the Mobilise-D DMOs. Questions such as "Are DMOs sensitive to change?" and "Can DMOs predict relevant medical outcomes?" can and should now be addressed as we progress toward regulatory qualification for use in healthcare and clinical trials.
"Implementation of the Mobilise-D methods by McRoberts represents a major milestone in delivering robust, valid digital mobility outcomes and marks an important step towards adoption in clinical trials and care." says Prof. Lynn Rochester, Professor of Human Movement Science at Newcastle University and co-lead of the Mobilise-D Consortium.
McRoberts is a service provider for collecting and analyzing human mobility data using wearable sensors. Our MoveMonitor and MoveTest solutions for free-living and in-clinic assessments are extensively validated and widelys used in academic research, clinical trials and healthcare. Please reach out to info@mcroberts.nl if you're interested in our services.